Intended Use

DeepRhythmAI is a cloud-based software for the assessment of cardiac arrhythmias using two lead ECG data in adult patients, intended for use by healthcare solution integrators to build applications allowing qualified healthcare professionals to review and confirm analytic results.

Technology

Software-only device utilizing a scalable Application Programming Interface (API) and a proprietary deep-learning algorithm to automatically detect cardiac beats, arrhythmias, and intervals from compatible ambulatory ECG recordings; designed for integration into other medical products without a primary user interface.

Performance

Performance testing was conducted following recognized standards ANSI/AAMI/IEC 60601-2-47:2012/(R)2016, AAMI/ANSI/EC57:2012, and FDA guidance on software validation. Testing showed the device meets intended use and is substantially equivalent to predicate devices, with no new safety or effectiveness issues.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    3/19/2021

    1 year, 4 months
  • 2

    FDA Approval

    7/27/2022

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.